Podcast Episodes

Back to Search
Shifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacement
Shifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacement

In this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll…

3 years, 8 months ago

Short Long
View Episode
Heath shares Stryker’s three commitments to build diversity in workplace, supplier base and beyond
Heath shares Stryker’s three commitments to build diversity in workplace, supplier base and beyond

In this episode, Annie Heath, Stryker’s vice president of diversity, equity and inclusion, explains how an interest in sales brought her to Stryker w…

3 years, 8 months ago

Short Long
View Episode
Is Medtech really recession proof? Recent layoffs, retrenchment may signal difficult times lie ahead
Is Medtech really recession proof? Recent layoffs, retrenchment may signal difficult times lie ahead

Medtech layoffs continue to mount. We’ll use this episode to begin to explore external and internal challenges. Looking externally, longtime industry…

3 years, 8 months ago

Short Long
View Episode
Hear from Medtech Color’s 10 Pitch Competition finalists; Kwame Ulmer joins us for the Newsmakers
Hear from Medtech Color’s 10 Pitch Competition finalists; Kwame Ulmer joins us for the Newsmakers

In this week’s episode, we’ll hear pitches from the 10 start-ups that have been selected as finalists for Medtech Color’s Pitch Competition. BIOMED –…

3 years, 8 months ago

Short Long
View Episode
State of Medtech Layoffs – Holly Scott on what can you do to find your next great opportunity
State of Medtech Layoffs – Holly Scott on what can you do to find your next great opportunity

Wow, I think we have a cool new format for the podcast! This was a fun one! Holly Scott, vice president and senior partner of the Mullings Group, an…

3 years, 9 months ago

Short Long
View Episode
Needham’s Matson, Saxon break down the Abbott-CSI and Globus-Nuvasive deals. Is more M&A on the way?
Needham’s Matson, Saxon break down the Abbott-CSI and Globus-Nuvasive deals. Is more M&A on the way?

The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solution…

3 years, 9 months ago

Short Long
View Episode
CEO Simhambhatla details how Setpoint Medical is poised to fulfill promise of bioelectronic medicine
CEO Simhambhatla details how Setpoint Medical is poised to fulfill promise of bioelectronic medicine

Murthy Simhambhatla launched his medtech career during the epic race to develop groundbreaking drug-eluting stent technologies as a new approach to b…

3 years, 9 months ago

Short Long
View Episode
Stryker’s Robert Cohen sees a new day dawning for surgical robotics, surgeons, data and digital tech
Stryker’s Robert Cohen sees a new day dawning for surgical robotics, surgeons, data and digital tech

Robert Cohen has his eyes on the future of orthopedic surgery, but he brings a wealth of knowledge about its past as well. In this interview, Cohen r…

3 years, 9 months ago

Short Long
View Episode
Hear about Dexcom's evolving mission statement and Medtronic's Cranial and Spinal Technologies plans
Hear about Dexcom's evolving mission statement and Medtronic's Cranial and Spinal Technologies plans

In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this mean for peop…

3 years, 10 months ago

Short Long
View Episode
Can Pristine Surgical’s single-use scopes, subscription model disrupt the rigid endoscope market?
Can Pristine Surgical’s single-use scopes, subscription model disrupt the rigid endoscope market?

Pristine Surgical CEO Bryan Lord spent his career advising and investing in medical device companies, so he didn’t immediately see how a “conspicuous…

3 years, 10 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us